| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| review article | Q7318358 |
| P50 | author | Sandrine Katsahian | Q56860990 |
| Michael Soussan | Q60325328 | ||
| Olivier Fain | Q114301300 | ||
| P2093 | author name string | Catherine Schramm | |
| Arsene Mekinian | |||
| Patrick Nicolas | |||
| Gabriel Pop | |||
| P2860 | cites work | 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides | Q28276589 |
| Meta-DiSc: a software for meta-analysis of test accuracy data. | Q31048578 | ||
| Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. | Q50951814 | ||
| Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter retrospective study. | Q51361285 | ||
| Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study. | Q53073312 | ||
| The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. | Q53142320 | ||
| Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. | Q53179293 | ||
| Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). | Q53348490 | ||
| Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch | Q73563567 | ||
| Giant cell arteritis: heterogeneity in clinical presentation and imaging results | Q81666296 | ||
| 18F-FDG PET as a diagnostic procedure in large vessel vasculitis—a controlled, blinded re-examination of routine PET scans | Q82037506 | ||
| Comparison of F18-FDG PET/CT findings with current clinical disease status in patients with Takayasu's arteritis | Q85212788 | ||
| Diagnostic performance of ¹⁸F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis | Q33895383 | ||
| Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients | Q33993390 | ||
| 18-FDG-PET in assessing disease activity in Takayasu arteritis: a meta-analysis. | Q34596153 | ||
| Diagnosis and follow up of aortitis in the elderly | Q35553422 | ||
| Non-invasive imaging in the diagnosis and management of Takayasu's arteritis | Q35554352 | ||
| The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis. | Q37944499 | ||
| Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features. | Q38098453 | ||
| FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review. | Q38152193 | ||
| Diagnostic and classification criteria of Takayasu arteritis | Q38181669 | ||
| Patterns of extracranial involvement in newly diagnosed giant cell arteritis assessed by physical examination, colour coded duplex sonography and FDG-PET. | Q40322778 | ||
| Fever of unknown origin as initial manifestation of large vessel giant cell arteritis: diagnosis by colour-coded sonography and 18-FDG-PET. | Q40352836 | ||
| Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for therapy evaluation of patients with large-vessel vasculitis. | Q40359743 | ||
| Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. | Q40562002 | ||
| Flourine-18 flourodeoxyglucose positron emission tomography as a non-invasive test of disease activity in Takayasu's arteritis--a report of four cases | Q43163472 | ||
| Evaluation of disease activity using F-18 FDG PET-CT in patients with Takayasu arteritis | Q43256312 | ||
| Takayasu arteritis | Q43829353 | ||
| Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio | Q43936771 | ||
| Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation | Q43982604 | ||
| The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries | Q44586619 | ||
| Fluorodeoxyglucose Uptake in the Aortic Wall at PET/CT: Possible Finding for Active Atherosclerosis | Q44639307 | ||
| The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis | Q44733480 | ||
| Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. | Q44823568 | ||
| Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides | Q45165581 | ||
| The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease | Q45300713 | ||
| Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? | Q46067926 | ||
| [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis | Q46361872 | ||
| Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. | Q46529195 | ||
| Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. | Q46724783 | ||
| MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis | Q46788879 | ||
| Role of imaging studies in the diagnosis and evaluation of giant cell arteritis in Japanese: report of eight cases | Q46810677 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Takayasu's arteritis | Q432462 |
| giant cell arteritis | Q707816 | ||
| meta-analysis | Q815382 | ||
| systematic review | Q1504425 | ||
| Fluorodeoxyglucose Positron Emission Tomography | Q130273243 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e622 | |
| P577 | publication date | 2015-04-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis | |
| P478 | volume | 94 |
| Q55312502 | 18F-FDG PET/MRI in the diagnosis of an infected aortic aneurysm. |
| Q52983704 | 18F-FDG uptake in main arterial branches of patients with large vessel vasculitis: visual and semiquantitative analysis. |
| Q90214581 | A Stab in the Dark: A Case Report of an Atypical Presentation of Giant Cell Arteritis (GCA) |
| Q30366333 | Altered Brain Glucose Consumption in Cogan's Syndrome. |
| Q47679456 | Can FDG-PET imaging play a role in guiding indications to endovascular treatments in patients presenting acute aortic syndromes? |
| Q37670335 | Characteristics of immunoglobulin G4-related aortitis/periaortitis and periarteritis on fluorodeoxyglucose positron emission tomography/computed tomography co-registered with contrast-enhanced computed tomography |
| Q90911186 | Clinical Factors Associated with Time-Specific Distribution of 18F-Fluorodeoxyglucose in Large-Vessel Vasculitis |
| Q52718727 | Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis. |
| Q55708968 | Concomitant Polymyalgia Rheumatica and Large-Vessel Vasculitis Visualized on 18F-FDG PET/CT. |
| Q49386796 | Correlation of FDG PET/CT Findings with Long-Term Growth and Clinical Course of Abdominal Aortic Aneurysm |
| Q64912977 | Delayed Diagnosis of Giant Cell Arteritis in the Setting of Isolated Lingual Necrosis. |
| Q38597229 | Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016. |
| Q48098620 | Diagnosis of Giant Cell Arteritis in an Asymptomatic Patient |
| Q90042821 | Diagnosis of giant cell arteritis by head-contrast three-dimensional computed tomography angiography: two case reports |
| Q92711416 | Diagnostic Performance of 18F-FDG PET/CT in Infectious and Inflammatory Diseases according to Published Meta-Analyses |
| Q58731411 | Differentiating Disease Flare From Infection: A Common Problem in Rheumatology. Do 18F-FDG PET/CT Scans and Novel Biomarkers Hold The Answer? |
| Q38601091 | Effect of CRP value on (18)F-FDG PET vascular positivity in Takayasu arteritis: a systematic review and per-patient based meta-analysis |
| Q38950827 | F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection |
| Q57152907 | FDG-PET imaging to detect and characterize underlying causes of fever of unknown origin: an unavoidable path for the foreseeable future |
| Q54238129 | FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. |
| Q39293033 | Giant Cell Arteritis - Beyond temporal artery biopsy and steroids. |
| Q61446893 | Giant cell arteritis: early diagnosis is key |
| Q92043510 | Immuno-Imaging to Predict Treatment Response in Infection, Inflammation and Oncology |
| Q99609027 | Large vessel vasculitis and the rising role of FDG PET-CT: A case report and review of literature |
| Q52937055 | Lesson of the month 1: Large vessel vasculitis - a diagnostic challenge and the role of 18-fluorodeoxyglucose positron emission tomography. |
| Q55339099 | Noninvasive aortic imaging. |
| Q92913591 | PET/MRI in large-vessel vasculitis: clinical value for diagnosis and assessment of disease activity |
| Q47836073 | Positron Emission Tomography as an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients with Large Vessel Vasculitis. |
| Q37605575 | Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: A real-life prospective study. |
| Q40152792 | Positron emission tomography/computed tomography in rheumatology |
| Q40096907 | Predictive value of (18)F-FDG PET/CT in patients with acute type B aortic intramural hematoma |
| Q47260070 | Relapses in three patients with Takayasu arteritis under tocilizumab treatment detected by contrast enhanced ultrasound |
| Q90678634 | Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study |
| Q90150340 | The Clinical Impact of Using 18F-FDG-PET/CT in the Diagnosis of Suspected Vasculitis: The Effect of Dose and Timing of Glucocorticoid Treatment |
| Q90620722 | The Role of Vascular Imaging to Advance Clinical Care and Research in Large-Vessel Vasculitis |
| Q64105015 | The impact of temporal artery biopsy for the diagnosis of giant cell arteritis in clinical practice in a tertiary university hospital |
| Q38915556 | The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease |
| Q52578815 | Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy. |
| Q33662694 | Variations in the clinical practice of physicians managing Takayasu arteritis: a nationwide survey |
| Q48027107 | [18F]-Sodium fluoride uptake in Takayasu arteritis |
| Q47617064 | [18F]FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis-lessons from a vasculitis clinic. |
| Q90198070 | [Imaging diagnostics in large vessel vasculitis] |
| Q52988169 | [Multiparametric imaging with simultaneous MRI/PET: Methodological aspects and possible clinical applications]. |
Search more.